Providing Solar-Powered Phototherapy and Maternal Health Education to Prevent Newborn Deaths from Jaundice in Rural Nigeria.
Limited awareness: Many families, especially in rural and underserved areas, are unaware of the symptoms or dangers of neonatal jaundice, often mistaking it for a harmless condition.
Inadequate healthcare infrastructure: A significant number of healthcare facilities, particularly in rural regions, lack basic phototherapy devices and trained healthcare providers capable of diagnosing and treating jaundice effectively.
Poverty and barriers to healthcare: Rural communities face significant challenges in accessing timely and quality healthcare services, further exacerbated by poverty, poor infrastructure, and cultural barriers to medical intervention.
The scale of the problem is staggering: an estimated 1.5 million newborns are affected by neonatal jaundice annually in sub-Saharan Africa, with a substantial proportion of those cases occurring in Nigeria.Neonatal jaundice is a preventable condition that is largely overlooked in public health interventions. In Nigeria, the lack of appropriate diagnostic tools, phototherapy equipment, and trained personnel continues to prevent effective management of the condition.
This crisis demands urgent attention. By addressing the root causes — including lack of awareness, insufficient healthcare infrastructure, and inadequate capacity building for healthcare workers — we can significantly reduce neonatal mortality rates in Nigeria. The proposed project, NeoVoltaic: Saving Newborn Lives with Solar Power in Rural Nigeria seeks to tackle these challenges through a multi-faceted approach that combines public education, healthcare system strengthening, and community empowerment. The goal is to reduce neonatal deaths caused by jaundice by 20% within the three years, while improving early detection, timely treatment, and long-term outcomes for newborns across the country.
Every year in Nigeria, thousands of newborns die from jaundice- a condition easily treatable with early intervention. In Sokoto and Borno States, where electricity is scarce, hospitals lack the power to run life-saving phototherapy machines. Mothers watch helplessly as newborns suffer — simply because there is no light.
NeoVoltaic is here to change that.
We are launching an integrated solution to save lives by:
Installing solar-powered phototherapy units and clean energy systems at 60 rural Primary Health Centres (PHCs)
Training 300 health workers and 12 local solar technicians for lasting impact
Launching LafiyarIyali, a WhatsApp chatbot offering maternal health education in local languages
Running community campaigns led by religious and traditional leaders to build trust and drive early healthcare-seeking behavior
In a small rural village outside Maiduguri, Aisha gave birth to her first son.
When he developed jaundice symptoms at two days old, the nearest hospital with working phototherapy was over 120 kilometers away.
The family could not afford transport. They tried local remedies — but the boy’s condition worsened, and he passed away at six days old.
With a solar-powered PHC near Aisha’s village, her baby’s life could have been saved.
This is why NeoVoltaic matters.
Save the lives of over 30,000 newborns annually by treating jaundice early
Provide solar-powered phototherapy treatment in underserved rural clinics
Train 300 health workers to diagnose and treat jaundice properly
Empower mothers through a WhatsApp chatbot delivering critical health education
Reduce CO₂ emissions by replacing diesel-powered generators with solar systems
How We Will Achieve Them:
Deploy full solar systems and phototherapy equipment at 60 PHCs
Conduct intensive, hands-on medical training for nurses and midwives
Train local solar technicians for maintenance and sustainability
Collaborate with religious and traditional leaders for public health campaigns
Continuously monitor progress with field reports and feedback from clinics
The $60,000 raised will be used for:
$55,800 value of installations and training, with discounts secured from technology partners
Solar Energy Systems: purchasing and installing solar panels and batteries
Phototherapy Devices: acquisition of durable, solar-compatible phototherapy units
Training Programs: covering curriculum development, trainers, materials, and workshops for health workers and technicians
Digital Health Tool: development and rollout of the LafiyarIyali (in Hausa Language, meaning family life) WhatsApp chatbot
Community Outreach: producing IEC materials (flyers, radio jingles, community meetings)
Monitoring and Evaluation: hiring field officers and data collection
Administration and Logistics: 7% for staff coordination, reporting, and project management
We aim to achieve high impact at a very lean cost, with detailed quarterly impact reporting.
CREACC-NG Core Team: Project management, clean energy, and healthcare integration experts
HealthVoltaic Project Leads: Experts who previously managed solar-powered rural clinics
Solar Engineers: In-house solar specialists with expertise in rural electrification
Maternal and Child Health Experts: Doctors and nurses with field experience
Community Mobilizers: Trained professionals in grassroots community engagement
Tech Developers: Building the LafiyarIyali chatbot
Proven Track Record:
CREACC-NG has already delivered successful clean energy + healthcare solutions across Nigeria, including:
We have successfully delivered all funded projects on time and within budget, maintaining strong reporting and donor satisfaction.
Possible Causes:
Insecurity and instability in some rural areas affecting deployment
Community resistance to new technologies if outreach is insufficient
Outcomes if it fails:
Continued high rates of preventable newborn deaths due to untreated jaundice
Missed opportunity to provide sustainable, renewable energy solutions to rural health centers
Loss of community trust in future health interventions
Mitigation Plans:
Engage community leaders and influencers early
Work with local NGOs and health departments for security updates
Partner with multiple technology suppliers to prevent equipment shortages
Establish flexible contingency plans for high-risk areas
CREACC-NG board members contribute $1,500 while staff contribute $400 for this challenging issue that is causing human lives
Impact-Driven Monitoring:
Donors will receive quarterly impact reports showing:
Number of newborns treated
Health center solar uptime
Success stories from mothers, nurses, and technicians.
Save the lives of over 30,000 newborns annually.
Serve over 64,800 mothers and newborns directly each year.
Reach over 500,000 community members with health education.
Reduce over 500 tons of CO₂ emissions by replacing fossil generators.
Build local green jobs and a culture of sustainable healthcare.
Every $50 saves a newborn. Every $2,000 powers a health center for years.
Your gift brings a future full of hope.
WATCH OUR PROJECT SHORT VIDEO- https://drive.google.com/file/d/1Hs3RrTkFnTLIR2zqvZLRGcAw5s97_oBs/view?usp=sharing
Comments
Carolina Oliveira
over 1 year agoHi there!
I would like to ask some clarifying questions (I hope they also help others gain clarity)
Is there a prototype for the solar-powered phototherapy units? Or is this something still in R&D? Which part of the funding goes to R&D, if it's still in this phase?
Who are the people responsible for the development and deployment of the intervention? I couldn't get a lot out of the links posted, there were no teams tagged, etc.
Where do the numbers of estimated impact come from? Are there any pieces of research you can point us to to understand the numbers in depth?
I look forward to understanding more of it and possibly donating. I believe it'll help your project if you share even beyond what I asked, if you have more info. Thank you!!
Tahir Mahmood Saleh
over 1 year ago@ollive Dear Carolina Oliveira,
Thank you so much for your thoughtful and important questions. We're grateful for your interest in supporting innovative, life-saving healthcare solutions like the solar-powered phototherapy units for neonatal jaundice. Below are detailed responses to your inquiries, and we’re happy to share further documentation as needed.
Prototype or R&D Status?
The Crib A’Glow phototherapy unit, developed by Tiny Hearts Technology, is not in the R&D phase. It is a fully developed and commercially available product that has already been deployed in over 500 hospitals across Nigeria, Ghana, Kenya, and Benin.
This means we are not seeking funds for prototyping or R&D. The request is strictly for procurement and deployment to healthcare facilities as part of our Neovoltaic Project—a health-energy intersection project targeting under-resourced areas.
Who Are the People Behind the Intervention?
The solar-powered phototherapy unit was invented by Virtue Oboro, a Nigerian visual artist and mother, whose personal experience with her jaundiced newborn inspired her to create Tiny Hearts Technology. She co-founded the company with her husband, a medical doctor, and they work with biomedical engineers and health experts to maintain and scale the intervention.
The development team includes:
Dr. Usman Muhammad Mareri- Director CREACC
Virtue Oboro – Product Innovator
Ahmad Janyau– Co-founder & Clinical Lead
Biomedical Engineers and Local Fabricators in Nigeria
Public Health Advisors and implementing partners (like us) who facilitate last-mile deployment.
Impact Numbers and Supporting Research
The impact estimates come from:
Internal monitoring by Tiny Hearts Technology, which reports that over 550,000 infants have been treated with Crib A’Glow since its launch.
Clinical trials and field evaluations conducted in Nigerian hospitals, which demonstrate that the device reduces the need for exchange blood transfusions by over 70% in moderate to severe jaundice cases.
Some useful sources:
https://drive.google.com/drive/home
CNN Feature on Crib A’Glow
Nigeria Health Watch – Case Study
We’re happy to provide further technical documentation, including:
Device technical manual
Published hospital outcomes
Deployment plans
Clinical partner references
In our Neovoltaic Project, we're integrating renewable energy with healthcare access to ensure life-saving devices like these can operate in off-grid or energy-poor areas. This unit directly supports SDG 3 (Good Health and Well-being) and SDG 7 (Affordable and Clean Energy).
We believe in evidence-based procurement and have chosen this device because it is cost-effective, proven, and scalable. Each unit can serve hundreds of infants annually, drastically improving neonatal survival in facilities where traditional phototherapy is unavailable or unreliable due to power cuts.
Thank you again for your interest. If you'd like, we can schedule a brief call or share a concept note, impact map, or deployment plan to provide even deeper insights.
Warm regards,
Tahir Mahmood Saleh
CREACC-NG – Neovoltaic Project
CREACC
contact@creaccng.org | 2348037816437| www.creaccng.org
Carolina Oliveira
over 1 year agoThank you for your swift reply, @Tahir-Mahmood-Saleh! I appreciate it. Follow-up clarifications (the last ones!):
Is NeoVoltaic officially working with Tiny Hearts Technology/acting in behalf of Tiny Hearts Technology? I understand they are also receiving donations to distribute the technology across Nigeria (and Ghana), so a bit more clarity if you're fundraising on behalf of them would be great!
Confusion in numbers
Your grant request states the project aims to "Save the lives of over 30,000 newborns annually by treating jaundice early" -- do you have more clarifications on that?
The reason for my confusion is that for now, according to the sources you've sent
- TinyHearts was started in 2016, so 9 years in activity
- TinyHearts website claims 550+ were saved by their technology
- Their technology is present in 400+ hospitals across Nigeria and Ghana with more than 1000 of their product deployed
Back of envelope:
~63 (precious! very precious!) lives per year. So very distant from what NeoVoltaic seems to be affirming.
NeoVoltaic wants to
- Install the technology that's present in 400+ hospitals in 60 locations
- Train 300 health workers (on using the technology, I assume?)
- Save 30,000 newborns annually -- and make Every $50 save a newborn.
I would really appreciate more clarification on these ambitions and claims!
Post script:
And while we don't know how much funding Tiny Hearts has gotten over their years of activity, let's just guess it's 400000 USD (even though highly unlikely, since cost per unit is 360 USD, so it should be superior?). This would be ~700 USD per life saved according to the website's numbers. Which, by the way, would be insanely impactful and worth checking if there's proof.
Looking forward to understanding this better, Tahir! Thank you so much.
Tahir Mahmood Saleh
over 1 year agoDear Carolina Oliveira,
Thank you once again for your thorough engagement, curiosity, and commitment to due diligence. These are exactly the kind of thoughtful questions that help refine and strengthen high-impact interventions, and I appreciate the opportunity to provide more clarity on the NeoVoltaic project and our collaboration with Tiny Hearts Technology.
NeoVoltaic is not officially fundraising on behalf of Tiny Hearts Technology. Rather, our project leverages their proven solution—Crib A’Glow phototherapy units—as a key component within a broader healthcare-energy access program we are implementing.
We are in active partnership discussions with Tiny Hearts to procure, deploy, and scale their technology in under-resourced primary health centers across Northern Nigeria, where power outages often render traditional phototherapy unusable. While Tiny Hearts is indeed receiving support directly for distribution, our role is contextual deployment, including:
Site assessments
Procurement through verified channels
Renewable energy integration
Training of healthcare workers
Monitoring and community engagement
This means NeoVoltaic complements, but does not duplicate, Tiny Hearts’ efforts. Our added value lies in reaching marginalized and energy-deficient areas, especially where solar integration is necessary for 24/7 functionality.
Clarifying the Impact Numbers
You're absolutely right to request clarity here, and I appreciate the opportunity to clarify both our projections and the context behind the numbers:
What We Stated:
“Save the lives of over 30,000 newborns annually by treating jaundice early.”
This is a forward-looking estimate based on:
Treating 500 newborns per year per device (based on current use data from hospitals using Crib A’Glow).
60 facilities × 500 = 30,000 newborns treated per year (not necessarily all at risk of dying, but at risk of complications or severe jaundice if left untreated).
This aligns with the assertion: "Every $50 saves a newborn", since the unit cost divided by expected beneficiaries supports this.
The 550+ figure quoted on Tiny Hearts’ website is likely a conservative direct estimate of lives saved (not just treated) based on cases that would have otherwise required exchange blood transfusion or resulted in fatality. However, over 550,000 newborns have been treated with the device since its inception (a much higher number). This is reflected in more recent publications and updates from the organization.
So to be clear: 30,000 newborns reached annually does not imply 30,000 lives saved directly. Rather, it represents at-risk infants who can be treated early and effectively due to access to functioning phototherapy, thus preventing complications, disabilities, or mortality.
We are currently working with clinical advisors to fine-tune these outcome metrics with evidence-backed conversion rates from treatment to lives saved. We’re also developing an impact dashboard to transparently communicate this distinction.
On Cost-Effectiveness and Value You're absolutely right that cost-effectiveness is key. Here's a quick summary:
Crib A’Glow unit cost: ~$360–400
Operational lifespan: 5–7 years
Patients treated annually per unit: 400–600
Cost per treated infant: $0.20–$0.30
Even if only 5–10% of those infants were at high risk of death or disability, the cost per life saved would remain extremely low and well-aligned with global benchmarks for cost-effective health interventions.
We are also preparing to:
Collect third-party validation of impact from facilities using the units
Track neonatal mortality reduction in each deployment site over time
Document case studies to support qualitative understanding
The NeoVoltaic Project is driven by urgency. Northern Nigeria has some of the highest neonatal mortality rates globally, much of it preventable. A significant number of these deaths are linked to untreated jaundice, and a lack of reliable power for medical equipment is a known bottleneck.
We are confident that by pairing proven technology with targeted training, solar energy, and community mobilization, this project will deliver sustainable, life-saving impact at scale.
Thank you again, Carolina Oliveira, for asking the right questions. We value your insights deeply, and we’re committed to transparency, effectiveness, and long-term results. I’d be happy to provide further documentation, cost breakdowns, or connect with Tiny Hearts’ leadership directly if needed.
Warm regards,
Tahir Mahmood Saleh
Programs Manager | CREACCNG.ORG
📧 tahirm@creaccng.org 🌍 www.creaccng.org
LinkedIn- https://www.linkedin.com/in/tahir-mahmood-saleh-354b24146/
@ollive